Mereo BioPharma Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.About MREO
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).
CEODenise Vera Scots-Knight
CEODenise Vera Scots-Knight
Employees39
Employees39
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2015
Founded2015
Employees39
Employees39
MREO Key Statistics
Market cap40.27M
Market cap40.27M
Price-Earnings ratio-1.45
Price-Earnings ratio-1.45
Dividend yield—
Dividend yield—
Average volume1.19M
Average volume1.19M
High today$0.2616
High today$0.2616
Low today$0.2451
Low today$0.2451
Open price$0.25
Open price$0.25
Volume802.79K
Volume802.79K
52 Week high$2.37
52 Week high$2.37
52 Week low$0.20
52 Week low$0.20
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
14.3%
Sell
14.3%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.